ROYAL BANK OF CANADA - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 90 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$63,000
+16.7%
101,030
-16.5%
0.00%
Q2 2016$54,000
+145.5%
121,025
+475.6%
0.00%
Q1 2016$22,000
-64.5%
21,025
-0.3%
0.00%
Q4 2015$62,000
-12.7%
21,089
-7.3%
0.00%
Q3 2015$71,000
-81.7%
22,753
-65.3%
0.00%
Q2 2015$389,000
+135.8%
65,646
+324.8%
0.00%
Q1 2015$165,000
-79.5%
15,455
-82.8%
0.00%
-100.0%
Q2 2014$806,000
+7.6%
89,713
-35.9%
0.00%0.0%
Q1 2014$749,000
+74800.0%
140,000
+36645.4%
0.00%
Q3 2013$1,0000.0%381
+83.2%
0.00%
Q2 2013$1,0002080.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2016
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,134,578$10,654,0007.22%
Consonance Capital Management LP 3,427,789$32,187,0004.15%
ACUTA CAPITAL PARTNERS, LLC 604,075$5,672,0003.83%
KOPP INVESTMENT ADVISORS LLC 758,233$7,119,0003.42%
Aisling Capital LLC 2,010,000$18,874,0002.86%
Broadfin Capital, LLC 6,100,000$57,280,0002.49%
THOMPSON DAVIS & CO., INC. 154,760$1,453,0001.68%
RUDMAN ERROL M 300,000$2,817,0001.14%
WALL STREET ASSOCIATES 1,259,500$11,827,0001.13%
Timpani Capital Management LLC 291,377$2,736,0001.08%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders